Results 1 to 10 of about 13,105,697 (337)

Both serum apolipoprotein B and the apolipoprotein B/apolipoprotein A-I ratio are associated with carotid intima-media thickness. [PDF]

PLoS ONE, 2013
BACKGROUND: Previous studies indicated that apolipoprotein measurements predicted cardiovascular disease (CVD) risk; however, associations between apolipoproteins and carotid intima-media thickness (CIMT) were less explored.
Fei Huang, Zhi Yang, Baihui Xu, Yufang Bi, Min Xu, Yu Xu, Jieli Lu, Yu Liu, Meng Dai, Wenzhong Zhou, Weiqing Wang, Yuhong Chen   +11 more
doaj   +6 more sources

Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain.

Journal of Biological Chemistry, 1987
Robert E. Pitas, J K Boyles, S H Lee, David Y. Hui, Karl H. Weisgraber   +4 more
openalex   +2 more sources

Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target

Metabolites, 2021
Apolipoprotein (apo) B, the critical structural protein of the atherogenic lipoproteins, has two major isoforms: apoB48 and apoB100. ApoB48 is found in chylomicrons and chylomicron remnants with one apoB48 molecule per chylomicron particle.
Jennifer Behbodikhah, Saba Ahmed, Ailin Elyasi, L. Kasselman, J. De Leon, A. D. Glass, A. Reiss   +6 more
semanticscholar   +1 more source

DIFFERENCES OF APOLIPOPROTEIN A1 AND APOLIPOPROTEIN B LEVELS IN TYPE 2 DIABETES MELLITUS (T2DM) PATIENTS WITH DIABETIC RETINOPATHY AND WITHOUT DIABETIC RETINOPATHY

IJRETINA (International Journal of Retina), 2021
Introduction Apolipoprotein A1 are antiatherogenic in blood serum and have an anti-inflammatory while Apolipoprotein B describes a protein structure that is potentially atherogenic..
shabrina hanifah, Angela Nurini Agni, Indra Tri Mahayana, Suhardjo Suhardjo, Teguh Triyono   +4 more
doaj   +1 more source

Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease

Alzheimer's & Dementia, 2021
We examine the role of brain apolipoprotein B (apoB) as a putative marker of early tau pathology and cognitive decline.
C. Picard, Nathalie I.V. Nilsson, A. Labonté, D. Auld, P. Rosa-Neto, N. Ashton, H. Zetterberg, K. Blennow, J. Breitner, S. Villeneuve, J. Poirier   +10 more
semanticscholar   +1 more source

Higher serum apolipoprotein B level will reduce the bone mineral density and increase the risk of osteopenia or osteoporosis in adults

Frontiers in Cell and Developmental Biology, 2022
Objective: There is very limited evidence in the NHANES database linking serum apolipoprotein B and lumbar bone mineral density (BMD) in adults aged 20–59 years.
RunJiu Zhu, RunJiu Zhu, Yuan Xu, Yuan Xu, ZhaoFu Wang, Hui Li, Hui Li, MingRui Song, MingRui Song, HaoYang Wan, HaoYang Wan, Hong Yang, Hong Yang, Xin Zhang, Xin Zhang, Yu Chai, Yu Chai, Bin Yu, Bin Yu   +18 more
doaj   +1 more source

Cholesterols, Apolipoproteins, and Their Associations with the Presence and Severity of Diabetic Retinopathy: A Systematic Review

Vision, 2022
Serum apolipoproteins have been reported as a more significant marker for diabetic retinopathy (DR) compared with serum cholesterols. This article aims to review the associations between serum cholesterols and apolipoproteins, and the presence and ...
Soefiandi Soedarman, King Hans Kurnia, Alberthus Donni Budi Prasetya, Muhammad Bayu Sasongko   +3 more
doaj   +1 more source

Assessment of apolipoprotein B/apolipoprotein A-I ratio in non-ST segment elevation acute coronary syndrome patients

The Egyptian Heart Journal, 2020
Background The apolipoprotein B/apolipoprotein A-I ratio was shown to be strongly related to the risk of myocardial infarction in several large-scale studies.
Haitham Galal, Ayman Samir, Mohamed Shehata   +2 more
doaj   +1 more source

Association of lowering apolipoprotein B with cardiovascular outcomes across various lipid-lowering therapies: Systematic review and meta-analysis of trials

European Journal of Preventive Cardiology, 2020
Aims The effect of therapeutic lowering of apolipoprotein B (apoB) on mortality and major adverse cardiovascular events is uncertain. It is also unclear whether these potential effects vary by different lipid-lowering strategies.
Safi U. Khan, Muhammad U Khan, Shahul Valavoor, M. Khan, Victor Okunrintemi, M. Mamas, T. Leucker, M. Blaha, E. Michos   +8 more
semanticscholar   +1 more source

Association of sleep duration with apolipoproteins and the apolipoprotein B/A1 ratio: the China health and nutrition survey

Nutrition & Metabolism, 2018
Background Short sleep duration has been related to established cardiovascular risk factors, likely obesity, diabetes, hypertension and dyslipidaemia.
Huihui Ren, Zhelong Liu, Xinrong Zhou, Gang Yuan   +3 more
doaj   +1 more source